magnetic resonance imaging |
47 |
humans |
34 |
male |
31 |
nasopharyngeal carcinoma |
29 |
covid-19 |
27 |
middle aged |
26 |
female |
24 |
atherosclerosis |
23 |
diffusion-weighted imaging |
23 |
mri |
23 |
pet/ct |
23 |
adult |
22 |
chinese |
22 |
deep learning |
21 |
prognosis |
21 |
intravoxel incoherent motion |
20 |
machine learning |
19 |
cervical cancer |
18 |
computed tomography |
18 |
diffusion tensor imaging |
18 |
positron emission tomography |
18 |
sars-cov-2 |
18 |
adc |
17 |
radiomics |
17 |
imaging |
16 |
cancer |
15 |
chemoradiotherapy |
15 |
dce-mri |
15 |
dementia |
15 |
randomized controlled trial |
15 |
anosmia |
14 |
cardiovascular magnetic resonance |
14 |
diffusion kurtosis imaging |
14 |
esophageal squamous cell carcinoma |
14 |
lung cancer |
14 |
neoadjuvant therapy |
14 |
olfactory dysfunction |
14 |
perfusion |
14 |
quality of life |
14 |
rheumatoid arthritis |
14 |
type 2 diabetes |
14 |
artificial intelligence |
13 |
diffusion magnetic resonance imaging |
13 |
positron-emission tomography |
13 |
standardized uptake value |
13 |
mind-body intervention |
12 |
non-small cell lung cancer |
12 |
thyroiditis |
12 |
aging - pathology |
11 |
alzheimer's disease |
11 |
anisotropy |
11 |
brain - pathology |
11 |
intensity-modulated radiation therapy |
11 |
liquid biopsy |
11 |
magnetic resonance spectroscopy |
11 |
mrs |
11 |
sensitivity and specificity |
11 |
thyroid function tests |
11 |
thyroid gland |
11 |
aging |
10 |
brain microstructure |
10 |
cognition |
10 |
cognitive behavioral therapy |
10 |
coronary artery disease |
10 |
delusional disorder |
10 |
diffusion |
10 |
f-dopa |
10 |
family caregiver |
10 |
first-episode psychosis |
10 |
functional connectivity |
10 |
functional outcome |
10 |
hong kong |
10 |
immunotherapy |
10 |
intracranial germ cell tumor |
10 |
magnetic resonance imaging - methods |
10 |
multidetector computed tomography |
10 |
negative symptoms |
10 |
neurotoxicity |
10 |
ovarian cancer |
10 |
plasma ebv dna |
10 |
radiation therapy |
10 |
schizophrenia |
10 |
striatal dopamine capacity synthesis |
10 |
stroke |
10 |
targeted therapy |
10 |
18f-fdg pet/ct |
9 |
4d flow |
9 |
aged |
9 |
chest x-ray |
9 |
cognitive behavioural therapy |
9 |
contrast-enhanced ct |
9 |
diagnosis |
9 |
diagnosis, differential |
9 |
dw-mri |
9 |
family caregivers |
9 |
nomogram |
9 |
outcome |
9 |
prediction model |
9 |
prevalence |
9 |
radiology |
9 |
recursive partitioning analysis |
9 |
resting-state fmri |
9 |
risk factors |
9 |
smell impairment |
9 |
stage classification |
9 |
survival prediction |
9 |
treatment outcome |
9 |
tumors |
9 |
vitamin a |
9 |
white cell count |
9 |
18f-fdg pet |
8 |
aerosolised |
8 |
alzheimer’s disease |
8 |
cardiovascular diseases |
8 |
case-control studies |
8 |
chemotherapy |
8 |
circulating neoplastic cell |
8 |
circulating tumor dna |
8 |
contrast media |
8 |
curriculum |
8 |
direct flow |
8 |
fdg-pet/ct |
8 |
fiber tracking |
8 |
functional brain network |
8 |
hfpef |
8 |
intraventricular flow |
8 |
long covid |
8 |
longitudinal real-time monitoring |
8 |
magnetic resonance cholangiography |
8 |
multi-detector computed tomography |
8 |
neuromyelitis optica |
8 |
non-invasive biomarker |
8 |
non-metastatic |
8 |
obesity |
8 |
observer variation |
8 |
oesophageal cancer |
8 |
oesophageal squamous cell carcinoma |
8 |
oesophagectomy |
8 |
olfactory training |
8 |
positron-emission tomography and computed tomography |
8 |
prognostic factors |
8 |
quantitative susceptibility mapping |
8 |
residual volume |
8 |
silver |
8 |
smell loss |
8 |
survival |
8 |
suv |
8 |
systemic lupus erythematosus |
8 |
ultrasound |
8 |
adolescent |
7 |
advanced escc |
7 |
aged, 80 and over |
7 |
alkaline phosphatase |
7 |
animals |
7 |
aorta |
7 |
arterial spin labeling |
7 |
azygos vein blood |
7 |
biliary |
7 |
brain |
7 |
breast cancer |
7 |
c-reactive protein - analysis |
7 |
cell-free dna |
7 |
cholangiogram |
7 |
chronic kidney disease |
7 |
circulating tumor cells |
7 |
circulating tumor cells (ctc) |
7 |
ctc clusters |
7 |
ctc enumeration |
7 |
diffusion magnetic resonance imaging - methods |
7 |
diffusion tensor imaging - methods |
7 |
diffusion weighted imaging |
7 |
dti |
7 |
early prediction |
7 |
emt |
7 |
epidemiology |
7 |
epithelioid |
7 |
gestational |
7 |
intracerebral hemorrhage |
7 |
ketamine |
7 |
lipid |
7 |
lymph node metastasis |
7 |
medical sciences |
7 |
medical students |
7 |
mild cognitive impairment |
7 |
parkinson's disease |
7 |
phantoms, imaging |
7 |
predictive value of tests |
7 |
public health |
7 |
screening |
7 |
substance abuse |
7 |
surgery |
7 |
tomography, spiral computed |
7 |
tomography, x-ray computed |
7 |
trophoblastic |
7 |
uterine cervical neoplasms |
7 |
adenocarcinoma |
6 |
alff |
6 |
alzheimer disease - pathology |
6 |
aorta, thoracic - pathology - radiography |
6 |
aortic diseases - epidemiology - radiography |
6 |
arterial calcification |
6 |
arthritis, rheumatoid - complications |
6 |
asymptomatic |
6 |
atherosclerosis - epidemiology - physiopathology - radiography |
6 |
atherosclerosis - epidemiology - radiography |
6 |
biological markers - analysis |
6 |
biomarker |
6 |
body mass index |
6 |
bone marrow |
6 |
c-reactive protein |
6 |
calcinosis - complications - epidemiology - radiography |
6 |
calcinosis - epidemiology - physiopathology - radiography |
6 |
calcinosis - etiology - radiography |
6 |
cardiovascular diseases - epidemiology - physiopathology - radiography |
6 |
cardiovascular system - pathology - physiopathology - radiography |
6 |
carotid arteries - pathology - radiography |
6 |
carotid artery diseases - epidemiology - radiography |
6 |
carotid artery diseases - epidemiology - ultrasonography |
6 |
carotid artery, common - radiography |
6 |
cerebral microbleeds |
6 |
cerebral small vessel disease |
6 |
cest |
6 |
comparative effectiveness |
6 |
computer tomography |
6 |
concurrent chemoradiotherapy |
6 |
coronary angiography |
6 |
coronary artery disease - epidemiology - radiography |
6 |
coronary artery disease - etiology - radiography |
6 |
coronary vessels - pathology |
6 |
cross-sectional studies |
6 |
diastolic function |
6 |
diffusional kurtosis imaging |
6 |
diffusivity |
6 |
disease progression |
6 |
dwi |
6 |
extracellular matrix |
6 |
extranodal |
6 |
family |
6 |
functional mri |
6 |
glioblastoma |
6 |
half-life clearance |
6 |
hardiness |
6 |
head and neck cancer |
6 |
hepatocellular carcinoma |
6 |
herbal medicine |
6 |
high cardiovascular risk |
6 |
hippocampus |
6 |
histogram analysis |
6 |
intervention research |
6 |
intervertebral disc |
6 |
intra-abdominal fat |
6 |
iron deposition |
6 |
ischemic stroke |
6 |
ivim |
6 |
kidney |
6 |
liver |
6 |
logistic models |
6 |
low-level laser irradiation |
6 |
lungquality of life |
6 |
lupus erythematosus, systemic - complications - physiopathology |
6 |
multimodal |
6 |
multiple sclerosis |
6 |
myelin |
6 |
neoadjuvant chemoradiotherapy |
6 |
neoplasm staging |
6 |
nerve fibers, myelinated - pathology |
6 |
obstructive sleep apnea |
6 |
oncology |
6 |
orthodontic pain |
6 |
orthodontic-periodontal joint treatment |
6 |
osteoarthritis |
6 |
palliative |
6 |
periodontal inflammation |
6 |
plasma epstein–barr virus deoxyribonucleic acid |
6 |
positron-emission tomography and computed tomography - methods |
6 |
prognostic factor |
6 |
prognostication |
6 |
prostate cancer |
6 |
psoriasis |
6 |
psoriasis - epidemiology |
6 |
psychological health |
6 |
psychometric validation |
6 |
radiogenomic |
6 |
randomised clinical trial |
6 |
rct |
6 |
recurrence |
6 |
regression analysis |
6 |
repetitive transcranial magnetic stimulation |
6 |
resilience |
6 |
resting state |
6 |
retrogenesis |
6 |
retrospective studies |
6 |
scleroderma, systemic - complications - radiography |
6 |
segmentation |
6 |
sleep apnea, obstructive - metabolism |
6 |
stress cardiac magnetic resonance |
6 |
tomography |
6 |
traditional chinese medicine |
6 |
ultrasonography |
6 |
ute |
6 |
vascular calcification |
6 |
vascular dementia |
6 |
visceral fat |
6 |
visual hallucinations |
6 |
visual spatial memory |
6 |
waist circumference |
6 |
white matter integrity |
6 |
18f-flutemetamol |
5 |
5-fluorouracil |
5 |
abdominal pregnancy |
5 |
acquired immunodeficiency syndrome - complications - diagnosis |
5 |
acupuncture |
5 |
adenosine triphosphate |
5 |
aetiology |
5 |
age-related degenerative disc change |
5 |
amygdala |
5 |
apparent diffusion coefficient |
5 |
basal ganglia |
5 |
bone marrow - pathology |
5 |
c6 glioma |
5 |
calcinosis - pathology - radiography |
5 |
capecitabine |
5 |
carcinosarcoma |
5 |
cerebral blood flow |
5 |
cerebral microbleed |
5 |
cervical spinal cord |
5 |
cetuximab |
5 |
child |
5 |
compressed sensing |
5 |
coronary artery disease - complications - radiography |
5 |
cryptococcosis - diagnosis - etiology |
5 |
ct |
5 |
diagnostic imaging |
5 |
diffusion weighting |
5 |
disc degeneration |
5 |
dynamic contrast-enhanced magnetic resonance imaging |
5 |
dysphagia |
5 |
ectopic pregnancy |
5 |
endplate defect |
5 |
fluorine-18-fluorodeoxyglucose |
5 |
fluorodeoxyglucose f18 - diagnostic use |
5 |
functional assessment |
5 |
gastric cancer |
5 |
gestational trophoblastic neoplasia |
5 |
gist |
5 |
glycosaminoglycan |
5 |
glycosaminoglycans - metabolism |
5 |
hcc |
5 |
head and neck cancers |
5 |
hemoperitoneum |
5 |
hodgkin disease - drug therapy - pathology |
5 |
imbalanced datasets |
5 |
interval debulking surgery |
5 |
intervertebral disc - metabolism |
5 |
intervertebral disc - pathology |
5 |
knee osteoarthritis |
5 |
lactate |
5 |
leiomyosarcoma |
5 |
liver fibrosis |
5 |
lumbar |
5 |
lumbar vertebrae - metabolism |
5 |
lumbar vertebrae - pathology |
5 |
lymphatic diseases - diagnosis - etiology |
5 |
lymphoma - diagnosis |
5 |
lymphoma, large b-cell, diffuse - drug therapy - pathology |
5 |
magnetic |
5 |
mediastinal neoplasms - drug therapy - pathology |
5 |
medical imaging |
5 |
metastatic |
5 |
metastatic colorectal cancer |
5 |
molecular size |
5 |
multidisciplinary management |
5 |
neo-adjuvant chemotherapy |
5 |
neural network |
5 |
neuromyelitis optica - diagnosis - pathology |
5 |
neurorehabilitation |
5 |
npc |
5 |
pain |
5 |
periodontitis |
5 |
peritoneal carcinomatosis |
5 |
pilot projects |
5 |
polycystic kidney disease |
5 |
positron-emission tomography - methods |
5 |
protocol |
5 |
radiotherapy |
5 |
random forest |
5 |
re-sampling techniques |
5 |
renal impairment |
5 |
resonance imaging |
5 |
scleroderma, systemic - complications - pathology |
5 |
sex |
5 |
sham acupuncture |
5 |
sinew acupuncture |
5 |
smell training |
5 |
spectral overlapping |
5 |
spinal cord - pathology |
5 |
staging |
5 |
statistics, nonparametric |
5 |
stress |
5 |
stretched exponential |
5 |
suvmax |
5 |
systemic treatment |
5 |
therapeutic evaluation |
5 |
tomography, x-ray computed - methods |
5 |
treatment failure |
5 |
tumour board |
5 |
tumour staging |
5 |
ultrashort time-to-echo |
5 |
uterine sarcoma |
5 |
2-[18f]fdg pet/ct |
4 |
3d voxels |
4 |
abdominal mri |
4 |
ablation techniques |
4 |
acute leukemia |
4 |
adpkd |
4 |
adrenal cortex hormones - therapeutic use |
4 |
algorithms |
4 |
amyloid-β protein (aβ) |
4 |
angiography |
4 |
anterior cingulate cortex |
4 |
antimicrobial resistance |
4 |
apoe ɛ4-negative |
4 |
apoe4 |
4 |
asia |
4 |
autosomal dominant polycystic kidney disease |
4 |
b-value |
4 |
bioinformatics |
4 |
blood volume |
4 |
body composition |
4 |
bold |
4 |
bone marrow - drug effects - pathology - radionuclide imaging |
4 |
brain tumor |
4 |
cancer management |
4 |
cell metabolism |
4 |
central executive network (cen) |
4 |
checkpoint inhibitor |
4 |
chemotherapy response score |
4 |
chest radiographs |
4 |
child, preschool |
4 |
chinese medicine |
4 |
citric acid cycle |
4 |
clinical trial |
4 |
colistin |
4 |
ct imaging |
4 |
data mining |
4 |
default mode network (dmn) |
4 |
diabetes |
4 |
diagnostic errors |
4 |
diffusion measurement |
4 |
diffusion time |
4 |
dimensionality reduction |
4 |
disease-free survival |
4 |
dynamic contrast enhanced |
4 |
egfr mutations |
4 |
ensemble 3d deep learning |
4 |
extramedullary |
4 |
extranodal extension |
4 |
fat–water decomposition mri |
4 |
fdg |
4 |
fdg pet/ct |
4 |
fdg-avid lymphoma |
4 |
fluorodeoxyglucose f18 |
4 |
fluorodeoxyglucose f18 - diagnostic use - pharmacokinetics |
4 |
fmri |
4 |
follow-up studies |
4 |
functional magnetic resonance imaging |
4 |
functional neuroimaging |
4 |
glucose metabolism |
4 |
glutamatergic system |
4 |
hands-on training |
4 |
heart |
4 |
hematological toxicity |
4 |
high-intensity focused ultrasound ablation |
4 |
human brain |
4 |
ileal neoplasms - drug therapy - pathology - radionuclide imaging |
4 |
image segmentation |
4 |
immune checkpoint inhibitor |
4 |
incidence |
4 |
indolent lymphoma |
4 |
interventional ultrasonography |
4 |
intervertebral disc degeneration |
4 |
intimate partner violence |
4 |
late-onset alzheimer's disease |
4 |
lean body mass |
4 |
learning |
4 |
low‐density lipoprotein cholesterol |
4 |
lymphoma |
4 |
magnetic stimulation |
4 |
management |
4 |
marrow biopsy |
4 |
mcr-1 |
4 |
meta-analysis |
4 |
metabolites |
4 |
metal-binding sites |
4 |
metalloenzymes |
4 |
metalloprotein |
4 |
metastasis |
4 |
mlkl |
4 |
monomorphic epitheliotropic intestinal t cell lymphoma |
4 |
multiplexed sensitivity encoding |
4 |
myeloid sarcoma |
4 |
neoadjuvant chemotherapy |
4 |
neoplasm metastasis |
4 |
neoplasm, residual |
4 |
neurological impact |
4 |
nodal staging |
4 |
nodular goiter |
4 |
normal-appearing brain tissues |
4 |
ovarian neoplasms |
4 |
peritoneal neoplasms |
4 |
pneumonia |
4 |
point-of-care ultrasound |
4 |
positron emission tomography computed tomography |
4 |
post-chemoradiation fibrosis |
4 |
post-stroke dysphagia |
4 |
prospective cohort study |
4 |
proteinuria |
4 |
proteoglycan |
4 |
psychological stress |
4 |
quantitative analysis |
4 |
quantitative mri analysis |
4 |
radiation dosage |
4 |
radiation dose |
4 |
radiopharmaceuticals - diagnostic use |
4 |
radiopharmaceuticals - diagnostic use - pharmacokinetics |
4 |
rat |
4 |
relaxometry |
4 |
relayed nuclear overhauser effect (rnoe) |
4 |
reproducibility of results |
4 |
resting state functional mri (rsmri) |
4 |
restricted diffusion |
4 |
salience network (sn) |
4 |
sarcoma, myeloid - drug therapy - pathology - radionuclide imaging |
4 |
sarcoma, myeloid - pathology - radionuclide imaging |
4 |
self-referential network (srn) |
4 |
semiquantitative analysis |
4 |
sensory motor network (smn) |
4 |
southern chinese |
4 |
spatial features |
4 |
stage iv |
4 |
stereotactic ablative radiation therapy |
4 |
stereotactic radiation therapy |
4 |
target therapy |
4 |
teaching |
4 |
thigh muscle segmentation |
4 |
tumor staging |
4 |
tumour stage |
4 |
valvular heart disease |
4 |
white matter hyperintensities |
4 |
whole exome sequencing |
4 |
whole-body mri |
4 |
x-ray computed |
4 |
x-ray computed tomography |
4 |
young adult |
4 |
acute disease |
3 |
acute kidney injury |
3 |
aflibercept |
3 |
american joint committee on cancer stages |
3 |
amyloidosis - diagnosis - etiology - pathology - radionuclide imaging |
3 |
angiogram |
3 |
appendicitis |
3 |
area under the curve |
3 |
artificial embolism |
3 |
b-values |
3 |
beam motion control |
3 |
bgcs |
3 |
bone |
3 |
brain functional connectivity |
3 |
brain topological organisation |
3 |
brainstem atrophy |
3 |
brainstem regional volume |
3 |
calcinosis - etiology - radionuclide imaging |
3 |
carcinoma - radiotherapy |
3 |
cardiac capacity |
3 |
cardiac imaging |
3 |
cardiac magnetic resonance imaging |
3 |
cardiac mri |
3 |
cardiorespiratory fitness |
3 |
cardiotoxicity |
3 |
causal inference |
3 |
cbct |
3 |
cell differentiation |
3 |
cephalometry |
3 |
cerebral infarction |
3 |
cerebral perfusion |
3 |
cervical carcinoma |
3 |
cest mri |
3 |
chinese herbal medicine |
3 |
cholangiocarcinoma |
3 |
circulating haemoglobin mass |
3 |
clinical assessment |
3 |
cognitive dysfunctions |
3 |
coils |
3 |
colorectal neoplasms |
3 |
comparability |
3 |
complete metabolic response |
3 |
computational biology |
3 |
computed tomography (ct), contrast enhancement |
3 |
cone beam |
3 |
cone beam computed tomography |
3 |
cone beam computerized tomography |
3 |
convolutional neural network |
3 |
corpus callosum |
3 |
cranial nerves |
3 |
cyclegan |
3 |
cyclophosphamide - therapeutic use |
3 |
cytoreduction |
3 |
damage control resuscitation |
3 |
deauville score (ds) |
3 |
difficult airway mangement |
3 |
diffusion weighted mrs |
3 |
diffusion-weighted mri |
3 |
disability |
3 |
discriminant analysis |
3 |
disease staging |
3 |
drug side effect |
3 |
drug-target interaction |
3 |
dynamic [ 18f]fluoro-2-deoxy-d-glucose pet |
3 |
echocardiography |
3 |
echocardiography parameters |
3 |
electronic health records |
3 |
endometrial carcinoma |
3 |
endovascular procedures |
3 |
entropy |
3 |
epidemiological characteristics |
3 |
extranodal natural killer/t-cell lymphoma (enktl) |
3 |
fabrication |
3 |
fibrosis |
3 |
figo |
3 |
first-episode schizophrenia |
3 |
fluorodeoxyglucose f 18 |
3 |
fluorodeoxyglucose f18 - pharmacology |
3 |
functional mrs |
3 |
gamma-aminobutyric acid |
3 |
genome-wide association studies |
3 |
germinoma |
3 |
germinomas |
3 |
glutamate |
3 |
gradient echo |
3 |
graph representation learning |
3 |
hans chinese |
3 |
heart rate |
3 |
hematoma |
3 |
hepatotoxicity |
3 |
hernia |
3 |
histologic subtypes |
3 |
histopathologic features |
3 |
hybrid control |
3 |
hydrogel |
3 |
hydronephrosis |
3 |
idiopathic pulmonary fibrosis |
3 |
image enhancement - methods |
3 |
image processing, computer-assisted |
3 |
image reconstruction |
3 |
imatinib |
3 |
immunoglobulin lambda-chains - analysis |
3 |
immunosuppressive agents |
3 |
inferior colliculus |
3 |
learning-based modulation |
3 |
left ventricular function |
3 |
liposome |
3 |
liver toxicity |
3 |
low-income countries |
3 |
lower-middle-income countries |
3 |
lupus nephritis - diagnosis |
3 |
lymph nodes - pathology - radionuclide imaging |
3 |
lymphatic diseases - etiology - pathology - radionuclide imaging |
3 |
lymphoepithelioma-like carcinoma |
3 |
lymphoma, large b-cell, diffuse - pathology - therapy |
3 |
magnetic resonance imaging (mri) |
3 |
magnetization transfer |
3 |
mantle cell lymphoma |
3 |
marek disease - diagnosis - etiology - radionuclide imaging |
3 |
mcnamara's analysis |
3 |
measurement |
3 |
mesenteric veins |
3 |
metagenomic sequencing |
3 |
metformin |
3 |
microbial communities |
3 |
mr angiography |
3 |
mr fingerprinting |
3 |
mr spectroscopic imaging |
3 |
multi-task learning |
3 |
multiple sclerosis (ms) |
3 |
multivariate analysis |
3 |
muscle |
3 |
myocarditis |
3 |
nasopharyngeal neoplasms - metabolism - pathology - radionuclide imaging - therapy |
3 |
nasopharyngeal neoplasms - metabolism - radionuclide imaging |
3 |
nasopharyngeal neoplasms - metabolism - radiotherapy |
3 |
neoplasm invasiveness - pathology |
3 |
nephrotic syndrome |
3 |
neurodegeneration |
3 |
neuroinflammation |
3 |
neurolymphomatosis |
3 |
neuromodulation |
3 |
neuromyelitis optica spectrum disorders |
3 |
neuromyelitis optica spectrum disorders (nmosd) |
3 |
neuropsychological assessment |
3 |
older age |
3 |
ophthalmic specialty clinics |
3 |
oral arsenic trioxide |
3 |
oral microbiome |
3 |
ovarian and peritoneal cancers |
3 |
ovarian carcinoma |
3 |
parallel imaging |
3 |
paraproteinemias - complications - diagnosis |
3 |
paraproteins - analysis |
3 |
percist |
3 |
perfusion imaging |
3 |
peritoneal pelvic packing |
3 |
permeability |
3 |
pet |
3 |
portal vein |
3 |
positron emission tomography-computed tomography |
3 |
positron-emission tomography - methods - utilization - veterinary |
3 |
pressure gradient manipulation |
3 |
prevalence in south-eastern chinese |
3 |
primary aldosteronism |
3 |
principal component analysis |
3 |
prognostic indicators |
3 |
prospective studies |
3 |
prostate |
3 |
proteinuria - drug therapy - etiology |
3 |
proton magnetic resonance spectroscopy |
3 |
psychiatry and neurology gerontology and geriatrics |
3 |
psychosis |
3 |
public health care system |
3 |
q-factor |
3 |
recovered |
3 |
recurrence detection |
3 |
refractory |
3 |
refractory hypertension |
3 |
regional adiposity |
3 |
relapsed |
3 |
renal cell carcinoma |
3 |
reproducibility |
3 |
resistant hypertension |
3 |
resnet |
3 |
response assessment |
3 |
response criteria |
3 |
response evaluation |
3 |
resting state functional mri |
3 |
resting-state functional magnetic resonance |
3 |
right ventricular function |
3 |
robot-assisted mrg-fus |
3 |
rosai-dorfman disease |
3 |
rucam |
3 |
run length |
3 |
secondary metabolites |
3 |
serum uric acid |
3 |
severity of illness index |
3 |
sex dimorphism |
3 |
side effect |
3 |
silent lacunes |
3 |
single-blind method |
3 |
sjogren's syndrome - diagnosis - etiology - pathology |
3 |
spin echo |
3 |
spine |
3 |
squamous cell carcinoma |
3 |
stroke - epidemiology |
3 |
survivors |
3 |
susceptibility weighted imaging |
3 |
synthetic magnetic resonance imaging |
3 |
systemic therapy |
3 |
target organ damage |
3 |
tetralogy of fallot |
3 |
texture analysis |
3 |
thrombophlebitis |
3 |
time factors |
3 |
total lesion glycolysis |
3 |
triage |
3 |
tricuspid regurgitation |
3 |
troponin |
3 |
tumor burden |
3 |
tumor debulking |
3 |
tumor heterogeneity |
3 |
type 2 diabetic mellitus |
3 |
untreated hypertension |
3 |
uterine cervical neoplasms - pathology - therapy |
3 |
v-net |
3 |
vagus nerve |
3 |
vascular cognitive impairment |
3 |
venous return |
3 |
volumetry |
3 |
voxel-mirrored homotopic connectivity |
3 |
wireless communication |
3 |
18f-fdg pet/ ct |
2 |
3d diffusion‐weighted imaging |
2 |
3d interleaved epi |
2 |
3d phase correction |
2 |
3d printing |
2 |
4d imaging |
2 |
68ga |
2 |
abdomen -- imaging. |
2 |
abdominal ct |
2 |
abiraterone (aa) |
2 |
absolute quantification |
2 |
acupuncture points |
2 |
acupuncture therapy |
2 |
acute appendicitis |
2 |
altitude |
2 |
altitude sickness |
2 |
alzheimer's disease - magnetic resonance imaging |
2 |
analysis |
2 |
analysis of variance |
2 |
ankylosing spondylitis |
2 |
anti-thyroglobulin autoantibody |
2 |
anticoagulants |
2 |
antineoplastic combined chemotherapy protocols - therapeutic use |
2 |
aorta, ct |
2 |
apalutamide |
2 |
apd |
2 |
aphasia |
2 |
aphasia - etiology - psychology - radiography - therapy |
2 |
arteries |
2 |
arteriovenous anastomosis - pathology |
2 |
arteriovenous malformation |
2 |
artifact removal |
2 |
artificial intelligence (ai) |
2 |
artificial neural network |
2 |
asian continental ancestry group |
2 |
astrocytoma |
2 |
atypical pneumonia |
2 |
automated segmentation |
2 |
autosomal dominant polycystic kidney disease (adpkd) |
2 |
awake |
2 |
axial spondyloarthritis |
2 |
balloon test occlusion |
2 |
bayesian estimation |
2 |
behcet disease |
2 |
behcet syndrome - radionuclide imaging |
2 |
benign |
2 |
benign thyroid nodule |
2 |
bile duct neoplasms - complications - radionuclide imaging |
2 |
biopsy, fine-needle |
2 |
blood oxygenation level-dependent |
2 |
blood-brain barrier |
2 |
body burden |
2 |
body water |
2 |
bowel |
2 |
brain abscess |
2 |
brain cortex |
2 |
brain edema |
2 |
brain imaging |
2 |
brain injuries - pathology |
2 |
brain ischemia - diagnosis - etiology |
2 |
brain ischemia - drug therapy - epidemiology - radiography |
2 |
brain ischemia - epidemiology |
2 |
brain malformation |
2 |
brain mapping |
2 |
brain metabolites |
2 |
brain neoplasms - blood supply - metabolism - pathology - secondary |
2 |
brain network |
2 |
breast |
2 |
breast neoplasms |
2 |
cad |
2 |
calcinosis - epidemiology - ethnology - radiography |
2 |
cancer incidence |
2 |
cancer mortality |
2 |
cancer patient |
2 |
cancer related symptoms |
2 |
cancer risk |
2 |
cancer survival |
2 |
capillary permeability |
2 |
capsulenet |
2 |
carcinoid tumor |
2 |
carcinoma - blood supply - metabolism - pathology - secondary |
2 |
carcinoma, renal cell - complications - radionuclide imaging |
2 |
carcinomatosis |
2 |
cardiac ct |
2 |
cardiac magnetic resonance |
2 |
cardiac tamponade - etiology |
2 |
cardiovascular magnetic resonance imaging |
2 |
cardiovascular mortality |
2 |
cardiovascular system |
2 |
cauda equina |
2 |
cbs (carotid blowout syndrome) |
2 |
cerebral angiography |
2 |
cerebral arteries - pathology - physiopathology - radiography |
2 |
chest |
2 |
chest ct |
2 |
chest radiograph |
2 |
children |
2 |
china |
2 |
cholangiocarcinoma - complications - radionuclide imaging |
2 |
choline |
2 |
chronic kidney failure |
2 |
chronic stroke |
2 |
classification |
2 |
clinical outcome |
2 |
cognition disorders |
2 |
cohort studies |
2 |
collagenase |
2 |
combined modality therapy |
2 |
comprehension - physiology |
2 |
computed tomography (ct) |
2 |
computed tomography (ct), contrast media |
2 |
computed tomography (ct), image processing |
2 |
computed tomography (ct), technology |
2 |
computed tomography (ct), three-dimensional |
2 |
computer automatic diagnosis |
2 |
computer-aided diagnosis (cad) |
2 |
contrast agents |
2 |
contrast media - administration and dosage |
2 |
contrast media - diagnostic use |
2 |
contrast media, experimental studies |
2 |
convolution neural network |
2 |
cord compression |
2 |
coronary angiography - methods - statistics & numerical data |
2 |
coronary microvascular disease |
2 |
cortical |
2 |
cranioplasty |
2 |
craniospinal irradiation |
2 |
ct coronary angiography |
2 |
data consistency |
2 |
decompressive craniectomy |
2 |
deep brain stimulation |
2 |
deep learning reconstruction |
2 |
diagnostic signs |
2 |
diagnostics |
2 |
diffusion magnetic resonance spectroscopy |
2 |
diffusion mri |
2 |
diffusion‐weighted imaging |
2 |
distant metastasis |
2 |
docetaxel |
2 |
dota |
2 |
drain |
2 |
dropout |
2 |
dura mater - pathology |
2 |
dynamic contrast-enhanced mri |
2 |
early detection |
2 |
echo-planar imaging |
2 |
echo‐planar imaging |
2 |
eddy current |
2 |
editorial |
2 |
effective connectivity |
2 |
egfr |
2 |
electrocardiography - methods |
2 |
emission-computed |
2 |
end-stage renal disease |
2 |
enzalutamide (enz) |
2 |
epilepsy - diagnosis - pathology - radionuclide imaging |
2 |
epithelial ovarian carcinoma |
2 |
esophageal neoplasms - complications - pathology - radiography |
2 |
esrd |
2 |
estimated glomerular filtration rate |
2 |
extracellular matrix - pathology |
2 |
extramedullary hematopoiesis |
2 |
false positive |
2 |
false positive reactions |
2 |
fasting |
2 |
faux pas |
2 |
feed forward neural network |
2 |
filum termniale |
2 |
fluids |
2 |
focused ultrasound |
2 |
frameless stereotaxis |
2 |
frontal lesions |
2 |
frontal lobe - pathology - physiopathology |
2 |
functional prediction |
2 |
gadolinium |
2 |
garadacimab |
2 |
gastrointestinal stromal tumor |
2 |
gastrointestinal stromal tumors |
2 |
gastrointestinal stromal tumors - complications - pathology - radiography |
2 |
gastrointestinal stromal tumors - pathology - radiography - radionuclide imaging |
2 |
gd-eob-dtpa |
2 |
general anaesthesia |
2 |
generative artificial intelligence |
2 |
generative network |
2 |
genetic algorithms |
2 |
glioblastoma - blood supply - metabolism - pathology |
2 |
glioma - blood supply - metabolism - pathology |
2 |
glomerular filtration rate |
2 |
glycoaminoglycan |
2 |
graphical processing unit |
2 |
graves’ disease |
2 |
gray matter |
2 |
hba1c variability |
2 |
heart failure |
2 |
heart rupture - etiology |
2 |
heart rupture, post-infarction |
2 |
hemangioblastoma |
2 |
hemangioblastoma - blood supply - pathology - surgery |
2 |
hematology |
2 |
hemorrhage |
2 |
hereditary angioedema |
2 |
hippocampal volumetry |
2 |
hong kong - epidemiology |
2 |
horseshoe kidney |
2 |
hydraulic systems |
2 |
hydropneumothorax |
2 |
hypothyroidism |
2 |
ileocecal |
2 |
image acquisition |
2 |
image enhancement |
2 |
image processing |
2 |
image quality |
2 |
image-guided radiotherapy |
2 |